Search Results
Jan 14, 2026, 09:00 ET Circle K Becomes First Major Convenience Chain in Texas to Sell THC Beverages, Launching With VARIN
exactly why we created VARIN. Our drinks combine hemp-derived THC with CBDV and select nootropics that boost mental performance like theobromine, L-theanine, lion's mane and B-12, to deliver a smooth, uplifting, feel-good-but-still-focused effect without the jitters or the crash. Putting VARIN in the cold
More news about: VARIN
Jan 14, 2026, 09:00 ET Silk Debuts New Plant-Based Protein Milk with 13g of Complete Protein
Haley [email protected] 1 IRI L52W 11/26/20232 Danone HCP Tracker Survey, 2025
More news about: Danone USA
Jan 14, 2026, 09:00 ET Parambil Raises $6M to Build the Future of Complex Litigation - And Transform Healthcare in the Process
litigation experience, and AI expertise. It's exactly the mix required to transform how complex cases are analyzed, valued, and resolved."Dr. Jeffrey L. Horstmyer, MD, PA, angel investor and practicing neurologist, said: "As both an investor and active user, Parambil is a world-class, high-trust AI platform
More news about: Parambil
Jan 14, 2026, 08:33 ET New Ownership of Longstanding PostalAnnex Location in Temecula, California Offering Shipping and Office Services for Over 20 Years
benefit from the more than 20 years of expert shipping and office services provided by this PostalAnnex location. Located at 27636 Ynez Rd., Ste. L7, in Temecula, CA 92591, this PostalAnnex is offering a comprehensive array of services, including shipping options with UPS, FedEx, USPS, and DHL, plus
More news about: Annex Brands, Inc.
Jan 14, 2026, 08:10 ET Catalyx dévoile une solution de dégagement de ligne activée par l'IA afin de réduire les goulots d'étranglement dans les sciences de la vie
rotation des lignes, d'améliorer la précision et d'offrir une solution conforme aux environnements modernes des sciences de la vie », explique Mario L. Rocci Jr, PDG de Catalyx. « Nous avons conçu le système avec une intelligence qui apprend, s'adapte et s'améliore chaque jour grâce au retour d'information
More news about: Catalyx
Jan 14, 2026, 08:04 ET Catalyx präsentiert KI-gestützte Lösung zur Linienfreigabe, um Produktionsengpässe in der Biowissenschaft zu reduzieren
Linienumschlag, verbesserte Genauigkeit und eine Lösung, die die Einhaltung von Vorschriften in modernen Life-Science-Umgebungen ermöglicht", sagte Mario L. Rocci Jr., CEO von Catalyx. „Wir haben das System mit einer Intelligenz entwickelt, die lernt, sich anpasst und sich jeden Tag durch geführte Rückmeldungen
More news about: Catalyx
Jan 14, 2026, 08:00 ET From Path to Progress: Journal of Independent Medicine Launches 2026 With Its Fifth Issue--Entering Year Two of Conflict-Free, Evidence-Based Science
societal harms. The Myth of the 'Correct' Sample Size: Why Formula-Based Justification Misleads Researchers and Reviewers — L. Prieto Valiente; C. Carazo Diaz; C. Marín BarcenaChallenges ritualized "correct N" demands, arguing that formula-based sample-size justification
More news about: Independent Medical Alliance
Jan 14, 2026, 07:37 ET Catalyx presenta una solución de limpieza de línea impulsada por IA
rotación de línea más rápida, mayor precisión y una solución que cumple con las normas para los entornos modernos de ciencias de la vida", afirmó Mario L. Rocci, Jr., consejero delegado de Catalyx. "Diseñamos el sistema con inteligencia que aprende, se adapta y mejora día a día mediante la retroalimentación
More news about: Catalyx
Jan 14, 2026, 06:17 ET Catalyx Unveils AI-Powered Line Clearance Solution to Reduce Manufacturing Bottlenecks in Life Sciences
manufacturing obstacle, providing faster line turnover, improved accuracy, and a compliance-enabled solution for modern life sciences environments," said Mario L. Rocci, Jr., CEO, Catalyx. "We designed the system with intelligence that learns, adapts, and improves every day through guided operator feedback and
More news about: Catalyx
Jan 14, 2026, 06:17 ET Catalyx Unveils AI-Powered Line Clearance Solution to Reduce Manufacturing Bottlenecks in Life Sciences
manufacturing obstacle, providing faster line turnover, improved accuracy, and a compliance-enabled solution for modern life sciences environments," said Mario L. Rocci, Jr., CEO, Catalyx. "We designed the system with intelligence that learns, adapts, and improves every day through guided operator feedback and
More news about: Catalyx
Jan 14, 2026, 06:15 ET Museum of Art + Light: Artistic Vision Meets the Power of Epson Projection Technology
Museum of Art + Light (MoA+L) in Manhattan, Kansas, art and technology converge to create immersive experiences that ignite imagination and redefine how audiences engage with creativity. As the first museum in the U.S. from its inception to unite digital, immersive and fine art, MoA+L is setting a new
More news about: Epson America, Inc.
Jan 14, 2026, 05:00 ET New Study Identifies Signature in Blood to Better Predict Type 2 Diabetes Risk
Yon Jung, Ching-Ti Liu, Nona Sotoodehnia, Simin Liu, Lesley F. Tinker, Robert E. Gerszten, Clary B. Clish, Liming Liang, Rozenn N. Lemaitre, Katherine L. Tucker, Stephen S. Rich, Jerome I. Rotter, Eric Boerwinkle, and Bing Yu.Disclosures: Rich is a consultant to Westat, the Administrative
More news about: Albert Einstein College of Medicine
Jan 14, 2026, 02:07 ET CZECHOSLOVAK GROUP announces planned IPO
addressable market expected to outgrow the defence supercycleThe Group is a manufacturer and supplier of a wide range of products including M&L calibre ammunition (for combat vehicles, artillery and tanks), Land Systems (such as military, wheeled and tracked vehicles, heavy off-road trucks,
More news about: CZECHOSLOVAK GROUP a.s.
Jan 13, 2026, 22:54 ET Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
I), comparing cadonilimab plus chemotherapy against a PD-1 inhibitor plus chemotherapy for the first-line (1L) treatment for advanced gastric (G) or gastroesophageal junction (GEJ) cancer with PD-L1 CPS <5 (a propensity-matched, retrospective cohort study). The study results showed that the cadonilimab
More news about: Akeso, Inc.
Jan 13, 2026, 20:18 ET Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
acquisition of a former Eli Lilly manufacturing facility located in Branchburg, New Jersey, securing 66,000L of drug substance (DS) capacity. The company plans to sequentially increase capacity to a total of 132,000L by 2030, while also extending its capabilities to include drug product (DP) facilities. Through
More news about: Celltrion
Jan 13, 2026, 18:46 ET Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
operation in 2027, each plant will include eight 15,000 L stainless steel bioreactors for commercial production, supported by multiple 3,000 L bioreactors for clinical-scale needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity.Guided by the vision
More news about: LOTTE BIOLOGICS
Jan 13, 2026, 18:00 ET Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes extensive analytical QC testing laboratories and warehouse facilities
More news about: Rakuten Medical, Inc.
Jan 13, 2026, 17:58 ET 2026 NAIC Committee Leaders Will Advance Work on Key Issues
Angela L. Nelson, Director, Missouri Department of Commerce and InsuranceFinancial Condition (E) Committee Chair:
More news about: NATIONAL ASSOCIATION OF INSURANCE COMMISSIONERS
Jan 13, 2026, 16:30 ET Hormel Foods To Hold 2026 Annual Meeting of Stockholders
Corporation (NYSE: HRL), a Fortune 500 global branded food company, will hold its 2026 Annual Meeting of Stockholders in person at Austin High School's Richard L. Knowlton Auditorium (300 NW 4th Street) in Austin, Minnesota. The meeting will be held at 6 p.m. CST on Tuesday, Jan. 27, 2026, and is open
More news about: Hormel Foods Corporation
Jan 13, 2026, 15:54 ET Consumer Watchdog says, Uber Needs to Disclose To Shareholders Its Executive's Conflict Of Interest On Contingency Fee Ballot Measure
courthouse," Sacramento Bee Opinion, November 18, 2025. Nora Freeman Engstrom is the Ernest W. McFarland Professor of Law and Co-Director of the Deborah L. Rhode Center on the Legal Profession at Stanford University. Brianne Holland-Stergar is Visiting Assistant Professor of Law at the University of Montana
More news about: Consumer Watchdog
Jan 13, 2026, 15:13 ET ST. CLOUD CAPITAL ANNOUNCES GROWTH CAPITAL INVESTMENT IN INTEGRATED DIAGNOSTIC SERVICES
with HCAP Partners, Southfield Mezzanine, and California Bank & Trust in providing capital to facilitate the transaction.Global law firm, K&L Gates LLP, served as counsel to St. Cloud Capital. For more information about IDS, please visit:
More news about: St. Cloud Capital
Jan 13, 2026, 14:54 ET Talon Air Continues Its Growth Trajectory as Independent Private Jet Management, Charter and Maintenance Company
[email protected], 631-427-1713Mark L. Smith, Epoch [email protected], 631-356-7097
More news about: Talon Air
Jan 13, 2026, 14:00 ET Freed-Hardeman University Celebrates 90th Annual Bible Lectureship With Focus on the Gospel of Matthew
this week will not only bless our campus but also the surrounding community and region."The 2026 FHU Bible Lectureship is dedicated to Dr. James L. and Becky Gardner, who have devoted decades to serving God's church, FHU and the countless students they have taught and mentored. An appreciation dinner
More news about: Freed-Hardeman University
Jan 13, 2026, 12:53 ET Lawmakers and Advocates urge Maryland to enact essential water quality management reforms to prevent spread of Legionella and Legionnaires' Disease
include:Public Water System Requirements:Maintain minimum detectable disinfectant levels (0.5 mg/L for chlorine; 1.0 mg/L for chloramine).Develop a distribution system maintenance plan to mitigate the risk of Legionella bacteria.
More news about: Prevent Legionnaires'
Jan 13, 2026, 12:33 ET Adimab Records Another Year of Double-Digit Clinical Program Growth
antibody authorized for prophylactic emergency use in the United States to prevent COVID-19 infection.Sun Pharma's UNLOXCYT™ (cosibelimab), a PD-L1 program approved in the United States for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma.There are numerous
More news about: Adimab, LLC